What is Aoti?
Aoti is a privately-owned company with operations in Oceanside, California, USA, and Galway, Ireland. The company specializes in providing innovative solutions to address severe and chronic wounds worldwide. Its core offering includes patented non-invasive Topical Wound Oxygen (TWO2) therapy, designed to reduce healthcare costs and enhance the quality of life for patients suffering from chronic wound conditions. The therapy is recognized for its efficacy in closing all types of chronic wounds.
How much funding has Aoti raised?
Aoti has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Aoti
PPP
Public-Private Partnership
What's next for Aoti?
With its recent large-scale late-stage funding, Aoti is poised for significant expansion and further development of its groundbreaking TWO2 therapy. This strategic capital infusion is expected to accelerate market penetration, enhance research and development efforts, and potentially scale manufacturing capabilities to meet global demand. The company's focus on improving patient outcomes and reducing healthcare expenditures positions it for sustained growth and leadership in the advanced wound care sector.
See full Aoti company page
